You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

9 Results
Guidelines and Advice
Status: Current
ID: PET 2015-2
May 2016
Guidelines and Advice
Status: Current
ID: 27-4
Mar 2016
Guidelines and Advice
Status: In-Review
ID: 2-11
Version: 4
Jun 2016
Guidelines and Advice
Status: In-Review
ID: 4-5
Jun 2016
Guidelines and Advice
Status: Archived
ID: 18-2
Sep 2016
Guidelines and Advice
Status: Current
ID: pet 2016-1
Nov 2016
Statistical Reports
Sep 2016
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
PERTuzumab (Unfunded),
trastuzumab,
PACLitaxel
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
New
Apr 2026
Regimen
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Drugs Used:
pembrolizumab (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
New
Apr 2026